about
Plant-produced viral bovine vaccines: what happened during the last 10 years?A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid ParticlesCurrent Status of Veterinary VaccinesStructure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine designChallenges of Generating and Maintaining Protective Vaccine-Induced Immune Responses for Foot-and-Mouth Disease Virus in PigsBioterrorism and the Role of the Clinical Microbiology LaboratorySerotype-Specific Transmission and Waning Immunity of Endemic Foot-and-Mouth Disease Virus in CameroonSerotype Diversity of Foot-and-Mouth-Disease Virus in Livestock without History of Vaccination in the Far North Region of CameroonInduction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopesExpression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine.New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccinesComparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching.Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination.Rescue of foot-and-mouth disease viruses that are pathogenic for cattle from preserved viral RNA samples.Bacterial ghosts as adjuvants: mechanisms and potential.An overview on ELISA techniques for FMD.Alternative way to test the efficacy of swine FMD vaccines: measurement of pigs median infected dose (PID50) and regulation of live virus challenge dose.Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.Challenges and economic implications in the control of foot and mouth disease in sub-saharan Africa: lessons from the zambian experienceDevelopment of a foot-and-mouth disease virus serotype A empty capsid subunit vaccine using silkworm (Bombyx mori) pupaeInterferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infectionPromising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine.Foot-and-mouth disease.A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-cell immunogen shows enhanced immunogenicity in mice.Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability.Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids.Research in advance for FMD novel vaccinesRandomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infectionNew approaches to rapidly control foot-and-mouth disease outbreaks.Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccinesSystemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.Evaluation of serological response to foot-and-mouth disease vaccination in BLV infected cowsLarge-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle.Use of adenoviral vectors as veterinary vaccines.Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattleFurther evaluation of an ELISA kit for detection of antibodies to a nonstructural protein of foot-and-mouth disease virusCharacterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.
P2860
Q26801335-7C7A8FBC-6EC4-4B19-9D08-2F276B2C59CDQ27339522-A08A86D5-25DD-424E-9AA6-5AB2B2A74F9EQ27480923-A1817AC5-4932-4D4E-A842-20833138ED10Q27702186-45EBCE3F-9EB2-4CC1-B2E0-1FD6B12669B4Q28080092-F8C4FD04-F973-4E83-9493-584D3F58F293Q28388247-500F0C69-1113-4178-B585-9C991FFB2AEAQ30151118-C51F583F-ABFB-4D60-BEAD-022C3D970AC1Q30210487-A3B75225-81A5-4F27-8E0E-E34D887B09EAQ33300592-BC902645-D7F4-48E9-B6B1-D210F8D1A9DCQ33338439-8349F5B8-1065-4E60-9605-FBD621DA28A4Q33573531-4916E329-587C-412D-9453-38024CCACC7CQ33601932-D14A36E7-0ED2-41AC-AFE9-ED3218F575C6Q33653450-4962BCCF-9D43-47C3-9790-A05B93225607Q33768731-9C7BF0DD-146B-4DE0-B6E9-519AACF55802Q33813196-424284E5-93F6-457B-9B49-72E04891FFF5Q33830398-A52D0E77-4022-4FCD-9CB2-119D14BFB0CEQ34010231-EA798968-74F2-4FD2-A6D9-88508A6BC9C5Q34148964-D47CFEB8-89E4-4895-9EF4-076049E1D093Q34149287-8A9088EB-418B-4542-AF49-F6DE93797CF5Q34152079-52E5D51E-7D75-47C3-857F-30281548A991Q34405725-B420B5DF-DCC1-4A68-9783-9AA8C7F2447BQ34427059-45A13817-0267-4ED5-99C6-B5C2A56A8579Q34484056-8273DC9F-C93E-4BB6-AB4D-18B348F169D6Q34547126-B61B99F5-314B-4308-A521-20052C9C4D4CQ34633536-5B41F3D4-8AB6-42C7-83FF-CEDCC60E5A10Q34743841-456BF0B7-6825-475A-9A71-BE7F4307BFDAQ34974075-FDBFBBE3-C99F-4D82-9AD7-21007F9CCA9FQ35054750-AA5EAFB7-62FD-412B-B233-CA29F2A19F4BQ35101293-57C8A109-BD99-4D3F-AF79-D75661DF87CBQ35852460-349DCC30-3DFD-4074-A03C-BE29D2D3297EQ35917287-C72E0A98-0C35-4C1B-9858-AE854B80E89BQ35966608-B0D05761-4E03-440F-ADA8-A42CAA091DECQ35973582-2B5C65CB-6421-4C9B-B7B4-DA7E34BA71AAQ36058279-D5ADDBDD-CEFC-4C89-82A9-94779E5C4389Q36066573-40337286-B410-4DA5-8FA4-EFAE546498C6Q36288927-818CB728-70B6-469A-AD11-044A413EA83DQ36350592-A8813FAB-4DB3-4B77-85AA-A6A21AD9664EQ36621746-DB2B90D1-59E7-4CEA-B6C5-409540F88EE1Q36792207-337FD747-9826-42AE-ABB6-9FAC6369758FQ37086101-D16E73BB-CECF-49B6-9F48-22ED58621E14
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
FMD vaccines.
@en
type
label
FMD vaccines.
@en
prefLabel
FMD vaccines.
@en
P1433
P1476
FMD vaccines.
@en
P2093
P356
10.1016/S0168-1702(02)00261-7
P577
2003-01-01T00:00:00Z